OTC · CIK 0001101026
ZIVO Zivo Bioscience, Inc.
Insider trading from SEC Form 4. Last filing Mar 3, 2026. Close $5.30 on Oct 9, 2026, +353% from the 52-week low and -69% from the high.
Zivo Bioscience, Inc. (ZIVO) has 22 SEC Form 4 filings on file from 5 insiders, the latest filed on Mar 3, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
18 open-market trades have been scored at ZIVO. The newest: Laith L Yaldoo (director and 10% owner) bought $15k of stock on Feb 27, 2026, filed Mar 3, 2026, scored 23 (weak). The largest of the 18 shown: Mark E Strome (10% owner) bought $1.5M on Dec 26, 2024, scored 38 (weak). 2 insiders bought within 14 days of each other around Feb 12, 2026.
ZIVO closed at $5.30 on Oct 9, 2026, 353% above its 52-week low and 69% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Zivo Bioscience, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Laith L Yaldoo director, owner buy | $15k 1,543 shares | +0% | +35% from low-55% from high | |
| 35Weak | Mark E Strome owner buy | $195k 20,000 shares | +4% | +42% from low-54% from high | |
| 31Weak | Laith L Yaldoo director, owner buy | $25k 2,434 shares | +0% | +45% from low-53% from high | |
| 48Moderate | Alison A Cornell director buy | $100k 11,709 shares | +4% | +40% from low-55% from high | |
| 68Notable | John Bernard Payne President and CEO buy | $100k 11,709 shares | +148% | +40% from low-55% from high | |
| 33Weak | Christopher D. Maggiore director, owner buy | $15k 1,766 shares | +0% | +29% from low-58% from high | |
| 38Weak | Laith L Yaldoo director, owner buy | $15k 1,766 shares | +0% | +29% from low-58% from high | |
| 23Weak | Laith L Yaldoo director, owner buy | $25k 2,777 shares | +0% | +49% from low-49% from high | |
| 43Moderate | Mark E Strome owner buy | $250k 20,259 shares | +5% | +32% from low-40% from high | |
| 38Weak | Laith L Yaldoo director, owner buy | $20k 1,659 shares | +0% | +32% from low-40% from high | |
| 52Moderate | Christopher D. Maggiore director, owner buy | $284k 23,682 shares | +5% | +20% from low-46% from high | |
| 47Moderate | Laith L Yaldoo director, owner buy | $245k 15,322 shares | +3% | +60% from low-28% from high | |
| 25Weak | Laith L Yaldoo director, owner buy | $50k 3,488 shares | +1% | +17% from low-37% from high | |
| 15Weak | Christopher D. Maggiore director, owner sell | $325 20 shares | -0% | +43% from low-23% from high | |
| 31Weak | Laith L Yaldoo director, owner buy | $177k 10,080 shares | +2% | +46% from low-21% from high | |
| 38Weak | Mark E Strome owner buy | $1.5M 75,000 shares | +23% | - | |
| 25Weak | Laith L Yaldoo director buy | $50k 3,133 shares | +1% | - | |
| 53Moderate | John Bernard Payne President and CEO buy | $100k 6,343 shares | +405% | - |
Transactions
Every row filed, 30 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Laith L Yaldoo director, owner | POpen-market purchase Common Stockindirect: HEP Investment, LLC | +1,543 | $9.72 | $15k | 583,615 | Mar 3, 2026 |
| Feb 12, 2026 | Mark E Strome owner | POpen-market purchase Common Stockindirect: By entity | +20,000 | $9.77 | $195k | 472,942 | Feb 17, 2026 |
| Feb 12, 2026 | Mark E Strome owner | POpen-market purchase Common Stock Purchase Warrantderivativeindirect: By entity | +2,000 | $0.00 | $0 | 45,071 | Feb 17, 2026 |
| Feb 10, 2026 | Laith L Yaldoo director, owner | POpen-market purchase Common Stockindirect: HEP Investments LLC | +2,434 | $10.27 | $25k | 582,072 | Feb 12, 2026 |
| Jan 26, 2026 | Alison A Cornell director | POpen-market purchase Common Stock | +11,709 | $8.54 | $100k | 279,481 | Jan 28, 2026 |
| Jan 26, 2026 | John Bernard Payne President and CEO | POpen-market purchase Common Stock | +11,709 | $8.54 | $100k | 19,618 | Jan 28, 2026 |
| Jan 14, 2026 | Christopher D. Maggiore director, owner | POpen-market purchase Common Stock | +1,766 | $8.49 | $15k | 519,292 | Jan 27, 2026 |
| Jan 14, 2026 | Laith L Yaldoo director, owner | POpen-market purchase Common Stockindirect: by HEP Investments LLC | +1,766 | $8.49 | $15k | 579,638 | Jan 27, 2026 |
| Nov 28, 2025 | Laith L Yaldoo director, owner | POpen-market purchase Common Stockindirect: by HEP Investments LLC | +2,777 | $9.00 | $25k | 577,872 | Dec 2, 2025 |
| Oct 13, 2025 | Mark E Strome owner | POpen-market purchase Common Stockindirect: By entity | +20,259 | $12.34 | $250k | 452,942 | Oct 20, 2025 |
| Oct 13, 2025 | Mark E Strome owner | POpen-market purchase Common Stock Purchase Warrantderivativeindirect: By entity | +2,025 | $0.00 | $0 | 43,071 | Oct 20, 2025 |
| Oct 10, 2025 | Laith L Yaldoo director, owner | POpen-market purchase Common Stockindirect: by HEP Investments LLC | +1,659 | $12.05 | $20k | 575,095 | Oct 14, 2025 |
| Oct 8, 2025 | Christopher D. Maggiore director, owner | POpen-market purchase Common Stock | +23,682 | $12.01 | $284k | 517,526 | Oct 9, 2025 |
| Oct 2, 2025 | Laith L Yaldoo director, owner | AGrant or award Nonstatutory Stock Options to buy Common Stockderivative | +926 | $10.20 | $9,445 | 926 | Oct 6, 2025 |
| Oct 2, 2025 | Christopher D. Maggiore director, owner | AGrant or award Nonstatutory Stock Options to buy Common Stockderivative | +1,075 | $10.20 | $11k | 1,075 | Oct 6, 2025 |
| Oct 2, 2025 | Alison A Cornell director | AGrant or award Nonstatutory Stock Options to buy Common Stockderivative | +1,223 | $10.20 | $12k | 1,223 | Oct 6, 2025 |
| Sep 30, 2025 | Laith L Yaldoo director, owner | POpen-market purchase Common Stockindirect: by HEP Investments LLC | +15,322 | $15.99 | $245k | 573,436 | Oct 2, 2025 |
| Jun 13, 2025 | Laith L Yaldoo director, owner | POpen-market purchase Common Stockindirect: By HEP Investments LLC | +3,488 | $14.33 | $50k | 558,114 | Jun 16, 2025 |
| Jun 13, 2025 | Laith L Yaldoo director, owner | POpen-market purchase Warrant for Common Stockderivativeindirect: By HEP Investments LLC | +348 | $14.33 | $4,987 | 348 | Jun 16, 2025 |
| Apr 8, 2025 | Christopher D. Maggiore director, owner | SOpen-market sale Common Stock | -20 | $16.25 | $325 | 507,000 | Apr 9, 2025 |
| Jan 22, 2025 | Laith L Yaldoo director, owner | POpen-market purchase Common Stockindirect: By HEP Investments LLC | +7,200 | $17.53 | $126k | 551,746 | Apr 4, 2025 |
| Jan 22, 2025 | Laith L Yaldoo director, owner | POpen-market purchase Common Stockindirect: By HEP Investments LLC | +2,880 | $17.53 | $50k | 554,626 | Apr 4, 2025 |
| Jan 1, 2025 | Alison A Cornell director | AGrant or award Common Stock | +1,516 | $0.00 | $0 | 259,491 | Jan 3, 2025 |
| Jan 1, 2025 | Alison A Cornell director | AGrant or award Common Stock | +8,281 | $0.00 | $0 | 267,772 | Jan 3, 2025 |
| Dec 26, 2024 | Mark E Strome owner | POpen-market purchase Common Stockindirect: By entity | +75,000 | $20.19 | $1.5M | 398,683 | Dec 31, 2024 |
| Dec 26, 2024 | Mark E Strome owner | POpen-market purchase Common Stock Purchase Warrantderivativeindirect: By entity | +7,500 | $0.00 | $0 | 44,171 | Dec 31, 2024 |
| Oct 16, 2024 | Laith L Yaldoo director | POpen-market purchase Common Stockindirect: By entity | +3,133 | $15.96 | $50k | 533,424 | Oct 17, 2024 |
| Oct 16, 2024 | Laith L Yaldoo director | POpen-market purchase Warrant to Purchase Common Stockderivativeindirect: By entity | +313 | $15.96 | $4,995 | 313 | Oct 17, 2024 |
| Oct 16, 2024 | John Bernard Payne President and CEO | POpen-market purchase Common Stock | +6,343 | $15.76 | $100k | 7,909 | Oct 16, 2024 |
| Oct 16, 2024 | John Bernard Payne President and CEO | POpen-market purchase Common Stock Warrantderivative | +634 | $15.77 | $9,995 | 634 | Oct 16, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Alison A Cornelldirector
- Christopher D. Maggioredirector, owner
- John Bernard PaynePresident and CEO
- Mark E Stromeowner, director
- Laith L Yaldoodirector, owner
Questions about ZIVO
Answered from the filings on this page, as of the latest one.
Are insiders buying ZIVO?
No. In the last 90 days no insider at Zivo Bioscience, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade ZIVO on the open market?
Laith L Yaldoo (director and 10% owner) bought $15k of ZIVO on Feb 27, 2026 and filed the Form 4 on Mar 3, 2026. InsiderTell scored 23 (weak).
How many insiders file Form 4 at Zivo Bioscience, Inc.?
5 people have filed a Form 4 at Zivo Bioscience, Inc., among them Alison A Cornell (director), Christopher D. Maggiore (director and 10% owner), John Bernard Payne (President and CEO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.